首页 | 本学科首页   官方微博 | 高级检索  
检索        


Controversy Over Radioiodine Ablation In Thyroid Cancer: Who Benefits?
Institution:1. Laboratory of Genital Tract Biology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women''s Hospital and Harvard Medical School, Boston, MA, USA;2. CONRAD, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA, USA;1. Department of Surgery, Georgia Regents University, Augusta, GA, United States;2. Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, United States;3. Department of Medicine, Georgia Regents University Augusta, GA, United States;4. Immunotherapy Center, Georgia Regents University Augusta, GA, United States;5. Genomics Core, Comprehensive Cancer Center, Georgia Regents UniversityAugusta, GA, United States;6. Center for Biotechnology and Genomic Medicine, Georgia Regents UniversityAugusta, GA, United States;7. Department of Biostatistics, Georgia Regents University, Augusta, GA, United States;8. Department of Medicine Georgia Regents University, Charlie Norwood VAMC, Augusta, GA, United States
Abstract:
Keywords:Thyroid cancer  Radioiodine ablation  RIA  Risk stratification  Overdiagnosis
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号